NPM1 and acute myeloid leukemia: Traditional induction therapies for NPM1-mutated AML in fit patients rely on intensive chemotherapy such as the classical 3 + 7 or regimens including additional drugs, such as FLAI (fludarabine, cytarabine, idarubicin).